NM_004239.4(TRIP11):c.5744GAA[3] (p.Arg1916_Thr1917insArg) AND Achondrogenesis, type IA

Germline classification:: Uncertain significance (1 submission)
Last evaluated:: May 17, 2024
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV003504715.4

Allele description [Variation Report for NM_004239.4(TRIP11):c.5744GAA[3] (p.Arg1916_Thr1917insArg)]

NM_004239.4(TRIP11):c.5744GAA[3] (p.Arg1916_Thr1917insArg)

Gene:

TRIP11:thyroid hormone receptor interactor 11 [Gene - OMIM - HGNC]

Variant type:

Microsatellite

Cytogenetic location:

14q32.12

Genomic location:

Preferred name:

NM_004239.4(TRIP11):c.5744GAA[3] (p.Arg1916_Thr1917insArg)

HGVS:

NC_000014.9:g.91969865TCT[3]
NG_016970.1:g.75191GAA[3]
NM_001321851.1:c.5741GAA[3]
NM_004239.4:c.5744GAA[3]MANE SELECT
NP_001308780.1:p.Arg1915_Thr1916insArg
NP_004230.2:p.Arg1916_Thr1917insArg
NC_000014.8:g.92436207_92436208insTTC
NC_000014.8:g.92436209TCT[3]

Links:

dbSNP: rs1566840867

Molecular consequence:

NM_001321851.1:c.5741GAA[3] - inframe_insertion - [Sequence Ontology: SO:0001821]
NM_004239.4:c.5744GAA[3] - inframe_insertion - [Sequence Ontology: SO:0001821]

Condition(s)

Name:: Achondrogenesis, type IA (ACG1A)
Identifiers:: MONDO: MONDO:0008701; MedGen: C0265273; Orphanet: 932; Orphanet: 93299; OMIM: 200600

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV004314188	Labcorp Genetics (formerly Invitae), Labcorp	criteria provided, single submitter (Invitae Variant Classification Sherloc (09022015))	Uncertain significance (May 17, 2024)	germline	clinical testing	PubMed (1) [See all records that cite this PMID]

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV004314188

Labcorp Genetics (formerly Invitae), Labcorp

criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))

Uncertain significance
(May 17, 2024)

germline

clinical testing

PubMed (1)
[See all records that cite this PMID]

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group, Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9..

PubMed [citation]

PMID:: 28492532
PMCID:: PMC5632818

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV004314188.3

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	PubMed (1)

Description

This variant, c.5747_5749dup, results in the insertion of 1 amino acid(s) of the TRIP11 protein (p.Arg1916dup), but otherwise preserves the integrity of the reading frame. This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with TRIP11-related conditions. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Apr 12, 2026

ClinVar

Relating variation to medicine